Navigation Links
Synthetic Biologics Reports Second Quarter 2014 Financial Results and Operational Highlights
Date:8/14/2014

urtis Donskey, M.D., Ciaran Kelly, M.D. and Tom Louie, M.D., formed to support clinical development of SYN-004.
  • Clinical microbiome study in collaboration with Enterome Bioscience expected to begin in second half of 2014.
  • Constipation-Predominant Irritable Bowel Syndrome (C-IBS) – SYN-010 Oral Compound
    Dr. Mark Pimentel of Cedars-Sinai Medical Center (CSMC), led the investigational team whose critical discoveries into the underlying cause of gas, pain and constipation associated with C-IBS established the foundation of Synthetic Biologics' C-IBS program, and are the basis for developing an oral treatment to reduce the impact of methane-producing organisms on conditions such as C-IBS. Of the 40 million IBS patients in the United States[v], approximately 13.2 million have C-IBS[vi].

    C-IBS Operational Highlights and Upcoming Milestones:

  • Initiation of a Phase II dose-discovery and proof-of-mechanism clinical trial of SYN-010 in C-IBS expected during the second half of 2014 under a corporate IND, with topline data expected mid-2015.
  • C-IBS CAB formed with Dr. Mark Pimentel as Chairman; in process of adding other prominent thought leaders and researchers in the field of C-IBS.
  • Synthetic Biologics to host an IBS investor day in New York on September 16, 2014, to provide an overview of the clinical development strategy for SYN-010, with Dr. Pimentel as keynote speaker.
  • Pertussis (Whooping Cough) – SYN-005 Monoclonal Antibody (mAb) Combination
    SYN-005, a unique combination of two humanized antibodies designed to target and neutralize pertussis toxin, a major cause of Pertussis-mediated infant morbidity and mortality, is being developed under an exclusive channel collaboration with Intrexon Corporation (NYSE: XON), and Synthetic Biologics' academic collaborator, The University of Texas at
    '/>"/>

    SOURCE Synthetic Biologics, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related biology technology :

    1. Synthetic Biologics Academic Collaborator to Present Novel Monoclonal Antibody Combination for Treatment of Whooping Cough (Pertussis) at 54th ICAAC
    2. Synthetic Biologics to Report Second Quarter 2014 Financial Results
    3. Synthetic Biologics on Track to Initiate Clinical Program for SYN-004 to Protect Against C. difficile
    4. Global Synthetic Biology Market 2014-2018
    5. Synthetic Biologics to Present at the 7th Annual OneMedForum San Francisco 2014 Conference
    6. Green Dot Develops Compostable Synthetic Leather Made with its Terratek® Flex Bioplastic
    7. Synthetic Biologics Announces Exercise of Underwriters Over-Allotment Option
    8. Synthetic Biologics Announces Proposed Public Offering of Common Stock
    9. Global Geosynthetics Market 2012-2016
    10. Process holds promise for production of synthetic gasoline
    11. Startup to Strengthen Synthetic Biology and Regenerative Medicine Industries with Cutting Edge Cell Products
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/22/2014)... , Oct. 22, 2014 Nuvilex, Inc. ... approximately 400 million people worldwide are living with diabetes, ... people by 2030.  The global market for diabetes treatments ... approximately 330,000 people worldwide died from pancreatic cancer.  Pancreatic ... due to cancer in the United States ...
    (Date:10/20/2014)... , Oct. 20, 2014 Mapp Biopharmaceutical,s ... ZMapp™ antibody therapeutic to fight the Ebola outbreak ... and time-consuming the production of pharmaceuticals can be, ... publisher said that while some may be taken ... compound, those with industry knowledge are well aware ...
    (Date:10/20/2014)... , October 20, 2014 , ... (GI) disorders and the delivery of care has revealed ... and worrying inequalities in the provision of healthcare services ... was commissioned by United European Gastroenterology (UEG), have been ... and public awareness of the burden of GI disorders ...
    (Date:10/20/2014)... Rochelle, Virginia (PRWEB) October 20, 2014 ... of NDA Partners LLC, announced today that Ellen ... and legal support for the pharmaceutical industry, has ... and manager of its legal services practice. ... reports and expert witness and testimony, to top ...
    Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 2Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 5NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice 2
    ... /PRNewswire-FirstCall/ - Neptune Technologies &,Bioressources Inc. ("Neptune") (NASDAQ.NEPT ... 2009 first quarter ended August 31, 2008., ... 31, 2008 was,$2,366,000 compared to $2,085,000 for the ... of 13.5%., The Company substantially decreased its ...
    ... best "gecko foot" dry adhesive got a new competitor this ... the journal Science by a team of researchers from four ... ability of gecko lizards to scurry up walls and cling ... amazing ability to microscopic branched elastic hairs in their toes ...
    ... 2 in ranking; up six spots from last year, ... recognition as a leader in biotechnology not just for its,ground-breaking ... Monsanto, headquartered in St. Louis, Missouri, took second place ... a leading,industry publication. The company moved up six spots from ...
    Cached Biology Technology:Neptune Technologies & Bioressources Inc. reports first quarter results 2Dry adhesive based on carbon nanotubes gets stronger, with directional gripping ability 2Dry adhesive based on carbon nanotubes gets stronger, with directional gripping ability 3Dry adhesive based on carbon nanotubes gets stronger, with directional gripping ability 4Monsanto Recognized as Top Biotechnology Employer by Science Magazine 2
    (Date:10/16/2014)... NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market announces ... the Smart Wallet, at the 13 th annual ... global conference on the intersection of technology and the ... , founder and publisher of the Strategic News Service™, ...
    (Date:10/15/2014)... rapidly and to an unexpected extent. The outbreak does ... the virus shows a new disease dynamic in regions, ... reason, the German National Academy of Sciences Leopoldina, acatech ... the Union of the German Academies of Sciences and ... today. , In the statement the academies call for ...
    (Date:10/14/2014)... – Like discriminating thieves, prostate cancer tumors scavenge and ... body. But such avarice may be a fatal weakness. ... way to kill prostate cancer cells by delivering a ... destroys the diseased cells brimming with the mineral, leaving ... two drugs already commercially available for other uses, could ...
    Breaking Biology News(10 mins):NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3Academies call for consequences from the Ebola virus epidemic 2Academies call for consequences from the Ebola virus epidemic 3Academies call for consequences from the Ebola virus epidemic 4Academies call for consequences from the Ebola virus epidemic 5Prostate cancer's penchant for copper may be a fatal flaw 2
    ... new study led by the Wildlife Conservation Society and Zoological ... the Sahara, has suffered a catastrophic collapse of its wildlife ... representing 28 scientific organizations assessed 14 desert species and found ... confined to one percent or less of their historical range. ...
    ... and described a new species of wild eggplant, found in ... cowiei , recently detailed his findings in the journal ... "gender bending," and explained that the females actually pretend to ... doing is duping bees into visiting their flowers," Martine said. ...
    ... ALEXANDRIA, Va.December 3, 2013Nearly two-thirds (65%) of Americans ... shutdown in the months ahead as Congress continues ... a new national public opinion poll commissioned by ... sentiment is shared across party affiliations: Democrats (66%), ...
    Cached Biology News:Study documents catastrophic collapse of Sahara's wildlife 2Unlikely collaboration leads to discovery of 'gender-bending' plant 2Unlikely collaboration leads to discovery of 'gender-bending' plant 3Majority of Americans believe another government shutdown likely in coming months 2Majority of Americans believe another government shutdown likely in coming months 3
    ... Ease of Use : GeneTraffic ... software tool for biological research. GeneTraffic provides ... to validate your data prior to analysis. ... Quickly define your projects using the MIAME ...
    ... rigid macroporous hydrophilic media. The rigid polymer ... pressures, while the macroporous beads enhance access ... reduces nonspecific binding. Macro-Prep High Q support ... very high flow rates and resolution. It ...
    ... siTrio siRNA --- a cocktail of 3 ... of interestis our most popular product. The ... 75% knockdown of your target gene when ... for transfection and confirmation of optimal transfection ...
    ... IDS 25-Hydroxy Vitamin D kit is ... determination of 25-hydroxyvitamin D (25-OH D) ... serum or plasma. Our patented DIRECT ... solvent precipitation and centrifugation and therefore ...
    Biology Products: